• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Swift Medical Launches AI Digital Wound App to Support Clinical Trials

by Jasmine Pennic 09/15/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Swift Medical Launches AI Digital Wound App to Support Clinical Trials

What You Should Know:

Global digital wound care provider Swift Medical, today announced the launch of a new application specifically designed to help pharma and med device researchers conduct decentralized clinical trials. Since patients are now doing more trials at home, study coordinators have had trouble tracking skin side effects remotely — or trusting patients to conduct adequate analysis and recording on themselves.

– Swift Medical’s first product, Swift Skin and Wound, provides an AI-powered, digital wound platform that allows any patient or clinician to easily capture high-precision images of skin or wound conditions with any smartphone camera. Swift Skin and Wound autonomously determines clinical characteristics, tracks disease progression, enables remote communication, and securely shares patient data in real-time.

To date, Swift Medical’s technology is used by more than 4,000 healthcare organizations internationally, including health systems and providers of all kinds, academic institutions, research organizations and pharmaceutical companies.

Why It Matters

The COVID-19 pandemic has made clinical trial participant recruitment more challenging while also creating new barriers to visit trial participants in person, resulting in longer and more expensive clinical trials. Because analyzing skin conditions during medical research is a critical part of the clinical trial process, Swift Medical was presented with a unique opportunity to support clinical trials across multiple sites without the need for expensive equipment by leveraging its technology. As a result, Swift Medical developed Swift Scientific to be a purpose-built tool that enables efficient and cost-effective decentralized clinical trials by allowing researchers to analyze skin and wound conditions from any smartphone.

“Organizations conducting and managing clinical trials are facing unprecedented challenges caused by the pandemic, yet their research is needed now more than ever. We’ve already proven that the Swift Medical platform can be a trusted solution for producing clinical-quality images, but now we see an opportunity to help researchers develop life-saving treatments in a faster, more efficient manner,” said Carlo Perez, co-founder and CEO of Swift Medical. “Even after the pandemic, decentralized clinical trials represent the future for medical research, giving applications like Swift Scientific unlimited potential to power the next generation of data collection and analysis.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, Artificial Intelligence, Clinical Trials

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Chipiron Secures $17M to Transform MRI Access with Portable Scanner

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Abbott to Integrate FreeStyle Libre Glucose Data with Epic EHR

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |